231 related articles for article (PubMed ID: 23678609)
1. [The present and the prospect of study on Blau syndrome/early-onset sarcoidosis].
Nakano M; Kambe N
Nihon Rinsho; 2013 Apr; 71(4):737-41. PubMed ID: 23678609
[TBL] [Abstract][Full Text] [Related]
2. Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis.
Okafuji I; Nishikomori R; Kanazawa N; Kambe N; Fujisawa A; Yamazaki S; Saito M; Yoshioka T; Kawai T; Sakai H; Tanizaki H; Heike T; Miyachi Y; Nakahata T
Arthritis Rheum; 2009 Jan; 60(1):242-50. PubMed ID: 19116920
[TBL] [Abstract][Full Text] [Related]
3. A case of infantile Takayasu arteritis with a p.D382E NOD2 mutation: an unusual phenotype of Blau syndrome/early-onset sarcoidosis?
Inoue Y; Kawaguchi Y; Shimojo N; Yamaguchi K; Morita Y; Nakano T; Arima T; Tomiita M; Kohno Y
Mod Rheumatol; 2013 Jul; 23(4):837-9. PubMed ID: 22821420
[TBL] [Abstract][Full Text] [Related]
4. A novel mutation in early-onset sarcoidosis/Blau syndrome: an association with Propionibacterium acnes.
Okazaki F; Wakiguchi H; Korenaga Y; Nakamura T; Yasudo H; Uchi S; Yanai R; Asano N; Hoshii Y; Tanabe T; Izawa K; Honda Y; Nishikomori R; Uchida K; Eishi Y; Ohga S; Hasegawa S
Pediatr Rheumatol Online J; 2021 Feb; 19(1):18. PubMed ID: 33602264
[TBL] [Abstract][Full Text] [Related]
5. Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis.
Caso F; Costa L; Rigante D; Vitale A; Cimaz R; Lucherini OM; Sfriso P; Verrecchia E; Tognon S; Bascherini V; Galeazzi M; Punzi L; Cantarini L
Autoimmun Rev; 2014 Dec; 13(12):1220-9. PubMed ID: 25182201
[TBL] [Abstract][Full Text] [Related]
6. Blau syndrome revisited.
Rose CD; Martin TM; Wouters CH
Curr Opin Rheumatol; 2011 Sep; 23(5):411-8. PubMed ID: 21788900
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of human NOD1 and NOD2 NACHT domains reveals different modes of activation.
Zurek B; Proell M; Wagner RN; Schwarzenbacher R; Kufer TA
Innate Immun; 2012 Feb; 18(1):100-11. PubMed ID: 21310790
[TBL] [Abstract][Full Text] [Related]
8. Blau syndrome-associated uveitis and the NOD2 gene.
Pillai P; Sobrin L
Semin Ophthalmol; 2013; 28(5-6):327-32. PubMed ID: 24010719
[TBL] [Abstract][Full Text] [Related]
9. Nucleotide-binding oligomerization domain containing 2: structure, function, and diseases.
Yao Q
Semin Arthritis Rheum; 2013 Aug; 43(1):125-30. PubMed ID: 23352252
[TBL] [Abstract][Full Text] [Related]
10. Blau syndrome, the prototypic auto-inflammatory granulomatous disease.
Wouters CH; Maes A; Foley KP; Bertin J; Rose CD
Pediatr Rheumatol Online J; 2014; 12():33. PubMed ID: 25136265
[TBL] [Abstract][Full Text] [Related]
11. Morphologic and immunohistochemical characterization of granulomas in the nucleotide oligomerization domain 2-related disorders Blau syndrome and Crohn disease.
Janssen CE; Rose CD; De Hertogh G; Martin TM; Bader Meunier B; Cimaz R; Harjacek M; Quartier P; Ten Cate R; Thomee C; Desmet VJ; Fischer A; Roskams T; Wouters CH
J Allergy Clin Immunol; 2012 Apr; 129(4):1076-84. PubMed ID: 22464675
[TBL] [Abstract][Full Text] [Related]
12. NOD2-associated diseases: Bridging innate immunity and autoinflammation.
Borzutzky A; Fried A; Chou J; Bonilla FA; Kim S; Dedeoglu F
Clin Immunol; 2010 Mar; 134(3):251-61. PubMed ID: 19467619
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotyping in peripheral blood mononuclear cells, aqueous humour and vitreous in a Blau syndrome patient caused by a novel NOD2 mutation.
Jimenez-Martinez MC; Cruz F; Groman-Lupa S; Zenteno JC
Int J Immunogenet; 2011 Jun; 38(3):233-42. PubMed ID: 21320290
[TBL] [Abstract][Full Text] [Related]
14. [Early-onset sarcoidosis/Blau syndrome].
Kambe N; Satoh T; Nakano M; Nakamura Y; Matsue H
Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(5):378-81. PubMed ID: 22041425
[TBL] [Abstract][Full Text] [Related]
15. Blau Syndrome: NOD2-related systemic autoinflammatory granulomatosis.
Takada S; Saito MK; Kambe N
G Ital Dermatol Venereol; 2020 Oct; 155(5):537-541. PubMed ID: 32618442
[TBL] [Abstract][Full Text] [Related]
16. [Clinical features of Blau syndrome and early-onset sarcoidosis and associating CARD15/NOD2 gene mutations].
Kanazawa N
Nihon Rinsho Meneki Gakkai Kaishi; 2007 Apr; 30(2):123-32. PubMed ID: 17473515
[TBL] [Abstract][Full Text] [Related]
17. Whole-exome sequencing in three children with sporadic Blau syndrome, one of them co-presenting with recurrent polyserositis.
Córdova-Fletes C; Rangel-Sosa MM; Martínez-Jacobo LA; Becerra-Solano LE; Arellano-Valdés CA; Tlacuilo-Parra JA; Galán-Huerta KA; Rivas-Estilla AM; Hernandez-Orozco AA; García-Ortiz JE
Autoimmunity; 2020 Sep; 53(6):344-352. PubMed ID: 32597225
[TBL] [Abstract][Full Text] [Related]
18. Blau syndrome NOD2 mutations result in loss of NOD2 cross-regulatory function.
Mao L; Dhar A; Meng G; Fuss I; Montgomery-Recht K; Yang Z; Xu Q; Kitani A; Strober W
Front Immunol; 2022; 13():988862. PubMed ID: 36189261
[TBL] [Abstract][Full Text] [Related]
19. [Mutations of NOD2 gene and clinical features in Chinese Blau syndrome patients].
Wang W; Wei M; Song H; Qiu Z
Zhonghua Er Ke Za Zhi; 2014 Dec; 52(12):896-901. PubMed ID: 25619344
[TBL] [Abstract][Full Text] [Related]
20. Blau syndrome polymorphisms in NOD2 identify nucleotide hydrolysis and helical domain 1 as signalling regulators.
Parkhouse R; Boyle JP; Monie TP
FEBS Lett; 2014 Sep; 588(18):3382-9. PubMed ID: 25093298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
